Skip to product information
1 of 1

GeneBio Systems

TNFRSF13C Polyclonal Antibody

TNFRSF13C Polyclonal Antibody

SKU:E-AB-16646

Regular price €490,95 EUR
Regular price Sale price €490,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: TNFRSF13C

Target Synonym: B cell activating factor receptor;B-cell-activating factor receptor;BAFF R;BAFF receptor;BAFF-R;BAFFR;BLyS receptor 3;BlySR3;BR 3;BR3;BROMIX;CD 268;CD268;CD268 antigen;CVID4;MGC138235;OTTHUMP00000028746;Prolixin;TNFRSF 13C;Tnfrsf13c;TR13C;Tumor necrosis factor receptor subunit member 13C;Tumor necrosis factor receptor superfamily member 13C

Research Areas: Cancer;Signal transduction

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: IHC

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: Q96RJ3

Accession:

Background: B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of Baff in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells. The protein encoded by this gene is a receptor for BAFF and is a type III transmembrane protein containing a single extracellular cysteine-rich domain. It is thought that this receptor is the principal receptor required for BAFF-mediated mature B-cell survival.

Concentration: 0.7 mg/mL

Immunogen: Synthetic peptide of human TNFRSF13C

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Dilution: IHC 1:50-1:200

Calculated MW:

ObservedMW:

View full details